Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva pharmaceutical industries limited | PDF
Our Products
Teva Pharmaceuticals - Wikipedia
TEVA 7543 Pill Blue & White Capsule/Oblong - Pill Identifier
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva secures US regulatory approval for generic version of Sabril
Teva Lifts Outlook With Drug Production Mostly Unaffected by War - Bloomberg
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S. | Fierce Pharma
Lillian Parris - Coordinator I - Teva Branded Pharmaceutical Products R&D, Inc. | LinkedIn
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Who's losing on Aurobindo's Novartis generics deal? Teva and Mylan, says analyst | Fierce Pharma